Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
31.50
+0.59 (1.91%)
Nov 11, 2026, 1:27 PM EST - Market open
Amylyx Pharmaceuticals Employees
Amylyx Pharmaceuticals had 136 employees as of December 31, 2025. The number of employees increased by 13 or 10.57% compared to the previous year. That makes Amylyx Pharmaceuticals the 29,489th largest employer in the world and 3,739th in the United States.
Employees
136
Change (1Y)
13
Growth (1Y)
10.57%
Revenue / Employee
n/a
Profits / Employee
-$1,199,963
Market Cap
4.05B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 136 | 13 | 10.57% |
| Dec 31, 2024 | 123 | -261 | -67.97% |
| Dec 31, 2023 | 384 | 122 | 46.56% |
| Sep 30, 2023 | 374 | 137 | 57.81% |
| Jun 30, 2023 | 338 | 112 | 49.56% |
| Mar 31, 2023 | 296 | 91 | 44.39% |
| Dec 31, 2022 | 262 | 57 | 27.80% |
| Sep 30, 2022 | 237 | 127 | 115.45% |
| Jun 30, 2022 | 226 | 116 | 105.45% |
| Dec 31, 2021 | 205 | 171 | 502.94% |
| Sep 30, 2021 | 110 | 76 | 223.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Amneal Pharmaceuticals | 8,700 |
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| Hims & Hers Health | 2,442 |
| HUTCHMED (China) | 1,790 |
| Lantheus Holdings | 1,193 |
| Supernus | 838 |
AMLX News
- 22 hours ago - Amylyx Pharmaceuticals Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 1 day ago - Amylyx price target raised to $39 from $38 at Mizuho - TheFly
- 2 days ago - Amylyx Pharmaceuticals Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 6 days ago - Amylyx Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 6 days ago - Amylyx Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 6 days ago - Amylyx Pharmaceuticals Earnings release: Q3 2026 - Filings
- 6 days ago - Amylyx reports Q3 EPS (38c), consensus (37c) - TheFly
- 6 days ago - Amylyx Pharmaceuticals Reports Third Quarter 2026 Financial Results - Business Wire